Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase 1 |
---|
Ligand | BDBM50195456 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_424982 (CHEMBL910739) |
---|
Kd | 13000±n/a nM |
---|
Citation | Chen, F; Hancock, CN; Macias, AT; Joh, J; Still, K; Zhong, S; MacKerell, AD; Shapiro, P Characterization of ATP-independent ERK inhibitors identified through in silico analysis of the active ERK2 structure. Bioorg Med Chem Lett16:6281-7 (2006) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase 1 |
---|
Name: | Mitogen-activated protein kinase 1 |
Synonyms: | ERK2 | ERT1 | Extracellular signal-regulated kinase 2 | Extracellular signal-regulated kinase 2 (ERK-2) | Extracellular signal-regulated kinase 2 (ERK2) | MAP Kinase 2/ERK2 | MAPK 2 | MAPK1 | MK01_HUMAN | Mitogen activated kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK2) | Mitogen-activated protein kinase 2 | PRKM1 | PRKM2 | p42-MAPK |
Type: | Ser/Thr Protein Kinase |
Mol. Mass.: | 41392.76 |
Organism: | Homo sapiens (Human) |
Description: | P28482 |
Residue: | 360 |
Sequence: | MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE
HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH
LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH
TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI
LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK
RIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
|
|
|
BDBM50195456 |
---|
n/a |
---|
Name | BDBM50195456 |
Synonyms: | CHEMBL221271 | N'-nitro-2-((5-(3-nitrophenyl)furan-2-yl)methylene)hydrazinecarboximidamide | N'-nitro-2-{[5-(3-nitrophenyl)-2-furyl]methylene}hydrazinecarboximidamide |
Type | Small organic molecule |
Emp. Form. | C12H10N6O5 |
Mol. Mass. | 318.245 |
SMILES | NC(N=NCc1ccc(o1)-c1cccc(c1)[N+]([O-])=O)=N[N+]([O-])=O |w:19.21,3.3| |
Structure |
|